Onco-Innovations Limited OverviewLatest ebit for ONCO.NE: $-12M, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of Jan 31, 2026
Trailing 12 months ending Jan 31, 2026
As of the most recent data (January 2026), ONCO.NE shows a EBIT of $-12M. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.
The Healthcare sector average EBIT is about $110B. Onco-Innovations Limited is at $-12M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how ONCO.NE stacks up against individual peers as well.
Tracking ONCO.NE's ebit over time shows whether Onco-Innovations Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $-12M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Onco-Innovations Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-12M) with ownership activity and broader fundamentals.
The Healthcare average EBIT is about $110B, while ONCO.NE is at $-12M. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
